Eloxx Pharmaceuticals (OTCMKTS:ELOX) major shareholder Gilad Shabtai acquired 8,300 shares of Eloxx Pharmaceuticals stock in a transaction on Wednesday, April 4th. The shares were bought at an average price of $9.46 per share, for a total transaction of $78,518.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Gilad Shabtai also recently made the following trade(s):
- On Thursday, March 29th, Gilad Shabtai acquired 4,500 shares of Eloxx Pharmaceuticals stock. The shares were bought at an average price of $9.64 per share, for a total transaction of $43,380.00.
Shares of Eloxx Pharmaceuticals stock traded down $0.15 during trading hours on Friday, reaching $10.20. The company’s stock had a trading volume of 7,161 shares, compared to its average volume of 9,501. Eloxx Pharmaceuticals has a one year low of $3.10 and a one year high of $10.75.
Receive News & Ratings for Eloxx Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eloxx Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.